๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Lymphokine-activated killer cell and interleukin-2 inhibitors: Their role in adoptive immunotherapy

โœ Scribed by Alexander M.M. Eggermont; Paul H. Sugarbaker

Book ID
113133941
Publisher
Elsevier Science
Year
1987
Tongue
English
Weight
766 KB
Volume
107
Category
Article
ISSN
0008-8749

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Adoptive immunotherapy for recurrent gli
Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin-2
โœ Randall E. Merchant; Angus J. Grant; Lynn H. Merchant; Harold F. Young ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 565 KB

Thirteen patients with recurrent glioblastoma were treated with adoptively transferred autologous lymphokine activated killer (LAK) cells and recombinant interleukin-2 (rIL-2). Patients' blood mononuclear cells (MNC) obtained by leukapheresis were cultured at 2.5 million MNC per ml for 3 to 5 days i

Adoptive immunotherapy with lymphokine-a
Adoptive immunotherapy with lymphokine-activated killer cells plus recombinant interleukin 2 in patients with unresectable hepatocellular carcinoma
โœ Saburo Onishi; Toshiji Saibara; Masanao Fujikawa; Hiroshi Sakaeda; Yasushi Matsu ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 591 KB

Ten patients with hepatocellular carcinoma, three of whom had pulmonary metastasis, were treated with adoptive immunotherapy using autologous lymphokineactivated killer cells plus recombinant interleukin 2. Patients received 16 pg per day of recombinant interleukin 2 consecutively (for 14 to 64 days